Teva Announces FDA Approval and Launch of Saxenda® – First Generic GLP-1 Indicated for Weight Loss
On Aug. 28, 2025, Teva Pharmaceuticals announced the U.S. Food and Drug Administration (FDA) approval and U.S. launch…
Genentech and Roche Break Ground on State-of-the-Art Manufacturing Facility in Holly Springs, North Carolina
On Aug. 25, 2025, Genentech, a member of the Roche Group broke ground on its newest U.S. manufacturing site…
Biotechnology | Disease | FDA | Medicine | Therapeutics
Novo Nordisk lowers cost of Ozempic® to $499 per month for self-paying patients
On Aug. 18, 2025, Novo Nordisk announced the launch of a new offer that enables self-paying, eligible, type…
Lilly signs $1.3 billion deal with Superluminal to discover obesity medicines using AI
On Aug. 14, 2025, Eli Lilly has signed a deal worth $1.3 billion with privately held Superluminal Medicines…
CagriSema 2.4 mg / 2.4 mg demonstrated 22.7% mean weight reduction in adults overweight or obesity in REDEFINE 1, published in NEJM
On Jun. 22, 2025, The New England Journal of Medicine (NEJM) published results from Novo Nordisk’s phase 3…
COVID-19 | Disease | Environmental | Infectious Disease | Influenza | Measles | Oncology | Vaccine
U.S. excess deaths continued to rise even after the COVID-19 pandemic
On May 23, 2025 a Boston University School of Public Health (BUSPH) led study revealed that there were…
New study aims to uncover the genetics of anorexia and other eating disorders
On May 19, 2025, researchers at the Broad Institute Ben Neale and Mark Daly are co-leading the study,…
Genetic Factors May Influence Liver Fat Even in Healthy Weight People
On May 15, 2025, researchers at the Translational Genomics Research Institute (TGen), part of City of Hope, announced…
Biotechnology | CDC | COVID-19 | Diagnostics | Disease | Genomics | NIH | Oncology | Radiology | Women's Health
Annual Report to the Nation Shows Cancer Deaths Continue to Decline
On Apr. 21, 2025, the National Institutes of Health (NIH) reported that overall death rates from cancer declined steadily among…
United States Dementia Cases Estimated to Double by 2060
On Jan. 13, 2025, a study led by NYU Langone Health shows that the risk of developing dementia at…
FDA Approved First Medication for Obstructive Sleep Apnea
On Dec. 20, 2024, the U.S. Food and Drug Administration (FDA) approved Eli Lilly’s Zepbound (tirzepatide) for the…
Agriculture | Biotechnology | Chemical | Environmental | FDA
FDA updates Definition of “Healthy Foods” For Packaging, first time in three decades
On Dec. 19, 2024, the U.S. Food and Drug Administration announced it had updated the definition of “healthy…
tRNAs Help Some mRNAs Get Lost in Translation
On Nov. 21, 2024, teams at the University of Texas Southwestern Medical Center report a new way that…
nearly 260 million people in the U.S. predicted to have overweight or obesity by 2050
On Nov. 14, 2024, an analysis from the Global Burden of Disease Study Collaborator Network warned of an…
Cleveland Clinic Study Identified Key Factors That Can Impact Long-Term Weight Loss in Patients with Obesity Prescribed GLP-1 RA Medications
On Sep. 13, 2024, a Cleveland Clinic study was announced that identified key factors that can impact the…
Lilly opened state-of-the-art research and development center in the Boston Seaport
On Aug. 13, 2024, Eli Lilly announced the opening of the Lilly Seaport Innovation Center (LSC), a research…
Novo Nordisk announced 4.1 billion USD investment to expand US manufacturing capacity
On Jun. 24, 2024, Novo Nordisk announced plans to invest 4.1 billion US dollars to build a second…
Biotechnology | FDA | Therapeutics | Vaccine
Wegovy received FDA approval for cardiovascular risk reduction in adults with known heart disease or obesity
On Mar. 8, 2024, the U.S. Food and Drug Administration approved a new indication for use of Novo…
FDA approved new medication for chronic weight management
On Nov. 8, 2023, the U.S. Food and Drug Administration approved Eli Lilly’s Zepbound (tirzepatide) injection for chronic…
Food allergy associated with lower risk of SARS-CoV-2 infection
On Jun. 1, 2022, the U.S. National Institutes of Health announced that an NIH funded study had found…
Vibativ effectively helped treat secondary bacterial infections in COVID-19 patients
On Jun. 21, 2021, Cumberland Pharma released a series of case reports describing the effectiveness of Vibativ (telavancin)…
FDA approved new rug treatment for chronic weight management, first since 2014
On Jun. 4, 2021, the U.S. Food and Drug Administration announced it had approved Novo Nordisk’s Wegovy (semaglutide)…
FDA approved new drug treatment for chronic weight management, first since 2014
On Jun. 4, 2021, the U.S. Food and Drug Administration approved Novo Nordisk’s Wegovy (semaglutide) injection (2.4 mg…
FDA approved Saxenda for the treatment of obesity in adolescents aged 12-17
On Dec. 4, 2020, Novo Nordisk announced that the FDA approved an updated label for Saxenda (liraglutide) injection…
Research confirmed obesity is a cause of kidney disease
On Nov. 4, 2020, scientists at the University of Oxford announced they had discovered that obesity can increase…
NIH-funded study linked adolescent brain differences to increased waist circumference
On Oct. 13, 2020, the National Institute on Drug Abuse (NIDA) and nine other institutes, all part of…
Factors inherent to obesity could increase vulnerability to COVID-19
On Sept. 15, 2020, UT Southwestern research suggested conditions related to obesity, including inflammation and leaky gut, leave…
USDA research showed higher carbohydrate and balanced fat intake can prevent certain diseases
On Sept. 15, 2020, a team of scientists in the U.S. Department of Agriculture’s (USDA) Agriculture Research Service…
NIH awarded $95 million for Einstein-Mount Sinai Diabetes Research Center
On Jul. 27, 2020, Albert Einstein College of Medicine announced that it had received a $9.5 million, five-year…
Biotechnology | Diagnostics | Disease | Non-Profit Research | Oncology | Therapeutics | Women's Health
The Cancer Prevention and Research Institute of Texas announced surpassed $2 billion in grants to fight cancer
On Aug. 24, 2018, the Cancer Prevention and Research Institute of Texas (CPRIT) announced it passed a $2…